VERU INC. DL-01
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includ… Read more
Market Cap & Net Worth: VERU INC. DL-01 (FMW)
VERU INC. DL-01 (F:FMW) has a market capitalization of $51.79 Million (€50.45 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #31141 globally and #3461 in its home market, demonstrating a 700.47% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VERU INC. DL-01's stock price €3.44 by its total outstanding shares 14658400 (14.66 Million).
VERU INC. DL-01 Market Cap History: 2015 to 2025
VERU INC. DL-01's market capitalization history from 2015 to 2025. Data shows growth from $19.83 Million to $51.79 Million (7.50% CAGR).
VERU INC. DL-01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VERU INC. DL-01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of FMW by Market Capitalization
Companies near VERU INC. DL-01 in the global market cap rankings as of March 19, 2026.
Key companies related to VERU INC. DL-01 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
VERU INC. DL-01 Historical Marketcap From 2015 to 2025
Between 2015 and today, VERU INC. DL-01's market cap moved from $19.83 Million to $ 51.79 Million, with a yearly change of 7.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €51.79 Million | +437.39% |
| 2024 | €9.64 Million | -5.24% |
| 2023 | €10.17 Million | -86.24% |
| 2022 | €73.92 Million | -4.98% |
| 2021 | €77.79 Million | -25.61% |
| 2020 | €104.57 Million | +157.41% |
| 2019 | €40.63 Million | +138.94% |
| 2018 | €17.00 Million | +15.78% |
| 2017 | €14.69 Million | +10.28% |
| 2016 | €13.32 Million | -32.85% |
| 2015 | €19.83 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of VERU INC. DL-01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $51.79 Million USD |
| MoneyControl | $51.79 Million USD |
| MarketWatch | $51.79 Million USD |
| marketcap.company | $51.79 Million USD |
| Reuters | $51.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.